JP Morgan Chase’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-332,548
Closed -$12.4M 5832
2018
Q1
$12.4M Buy
+332,548
New +$14M ﹤0.01% 1863

JP Morgan Chase's ARMO Position: Q2 2018 in Review

JP Morgan Chase sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 332,548 shares — an estimated $12.4M sold.

JP Morgan Chase first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $12.4M in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

  • JP Morgan Chase reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • JP Morgan Chase sold 332,548 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $12.4M.
  • JP Morgan Chase first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • JP Morgan Chase's ARMO BioSciences, Inc. Common Stock position peaked at $12.4M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.